
Michael Kappelman, MD, MPH
@michaelkappel12
Professor of Pediatrics, Inflammatory Bowel Disease Specialist, University of North Carolina at Chapel Hill
ID: 1259893501527052288
11-05-2020 17:12:30
18 Tweet
410 Takipçi
118 Takip Edilen


It's amazing to see how patients and their physicians are using SECURE-IBD to make important, more informed health choices! Secure IBD Erica Brenner MD, MSCR Ryan Ungaro MD MS Jean-Frederic Colombel #WORLDIBDDay

Looking forward to this great program with Michael Kappelman, MD, MPH on initiatives on #COVID19 and #ibd through Secure IBD and #ibdpartners, thank you Crohn's & Colitis Foundation for having us!

@DoctorTennyson New York Times Books Hats off to former UNC Gastroenterology fellow Dr Will Bulsiewicz!







Empowering Patients,LLC • Alison Over The 🌕 Vanessa Lamers, MESc, MPH Carol Forden💉💉💉 Paul Offit @ZDoggMD Gil Y. Melmed, MD, MS Ryan Ungaro MD MS Dr Dermot McGovern David T. Rubin, MD Parakkal Deepak MD, MS, FACG Dr Mark Silverberg Michael Kappelman, MD, MPH Peter Higgins Shrinivas Bishu Yes - the PREVENT COVID study is measuring antibody response in #IBD patients, visit ibdpartners.org/preventcovid to learn more! As part of the study, we are partnering with LabCorp to draw these important titers. Empowering Patients,LLC • Alison - another great study is available by Gil Y. Melmed, MD, MS!

How do patients with #IBD on #tofacitinib fare when faced with #COVID19? Results from Secure IBD give some guidance & show outcomes similar to other IBD meds. @manasiagrawalMD Ryan Ungaro MD MS Jean-Frederic Colombel Michael Kappelman, MD, MPH irene modesto Erica Brenner MD, MSCR bit.ly/3s0sI4X

